Antiretroviral Therapy

Millions of children in Africa rely on funding from the United States for HIV care or testing — support that was threatened last month when President Donald J. Trump froze foreign aid spending after taking office.

Adults in Tanzania living with HIV and taking tenofovir have a higher rate of chronic kidney disease vs. those without the viral infection, according to a prospective cohort study.

For organ transplant recipients with HIV, kidneys from deceased donors with HIV are noninferior those from donors without HIV, according to data from a U.S. multicenter observational trial.

HHS this week announced that it will allocate more than $1.4 billion in funding through the Ryan White HIV/AIDS Program to help people with HIV who have low incomes receive medication and care.

People with virally suppressed HIV who are hospitalized with community acquired pneumonia do not have a higher mortality risk than people without HIV, according to a study.

In June, Gilead Sciences announced that its investigational antiretroviral drug lenacapavir prevented 100% of new HIV infections during a phase 3 trial conducted among cisgender women in Africa.

Patients with HIV who undergo immediate antiretroviral therapy may not experience significant differences in chronic kidney disease outcomes compared with patients who defer treatment.

Sporotrichosis, a fungal infection being transmitted by feral cats, is a potential threat on the CDC’s radar.

DENVER — Long-acting ART was shown to be safe and effective in a study conducted in sub-Saharan Africa — an “essential first step” in demonstrating its potential use to treat HIV on the continent, an expert said.